Cutting-edge trials of new therapies for early-stage non-small cell lung cancer are critical to fostering better patient care, but interpreting their findings can be a challenge. Here's why.
An up-and-coming biotech company wanted peer-reviewed journal publication highlighting their technology. We transformed market research data into an academic article published in Open Access Rheumatology
This report for a medical device manufacturer included in-depth analysis of the peer-reviewed literature to explore an important advance in the treatment of central nervous system tumors.
Produced for a medical communications company on behalf of a medical device manufacturer for B2B promotion of an intraoperative radiotherapy device.
This article, which was published in the Journal of Managed Care Pharmacy, examined the extent, nature, and range of risk arrangements between physician groups and health maintenance organizations (HMOs) for self-administered injectable (SAI) drugs.
Communicating complex policies in accessible formats is critical for influencing decisionmakers and key opinion leaders.
Agnew & Associates Medical Writing
Copyright © 2023 Agnew & Associates Medical Writing - All Rights Reserved.
Powered by GoDaddy